WILMINGTON, Del.--(BUSINESS WIRE)-- Noramco, a leading global active pharmaceutical ingredients (API) manufacturer, specializing in controlled substances, announced today it has completed the acquisition of the Cambrex Drug Product Business Unit previously known as Halo Pharmaceuticals. This acquisition will provide API customers of Noramco, and its subsidiary Purisys, additional service options such as drug product formulation development, clinical and commercial drug product manufacturing, and packaging from facilities in Mirabel, Québec and Whippany, New Jersey.

WILMINGTON，Del.-（BUSINESS WIRE）-专门从事受控物质的领先全球活性药物成分（API）制造商Noramco今天宣布已完成收购Cambrex药品业务部门，该部门以前称为Halo Pharmaceuticals。此次收购将为Noramco及其子公司Purisys的API客户提供其他服务选项，如药品配方开发，临床和商业药品制造以及新泽西州魁北克和惠帕尼的Mirabel工厂的包装。

Noramco is returning to the Halo Pharmaceutical brand as part of this acquisition..

作为此次收购的一部分，Noramco将回归Halo制药品牌。。

“This acquisition allows Noramco to provide our customers with more sourcing options beyond APIs. With these additional capabilities, Noramco/Purisys customers can develop drug product formulations for their APIs for both clinical and commercial purposes,” said Noramco CEO Lee Karras. “Having previously operated the Halo Pharmaceuticals business, I have a direct appreciation of the capabilities of both sites and look forward to working with existing and future customers while welcoming the almost 400 new employees to the Noramco group of companies.”.

Noramco首席执行官Lee Karras说：“这一收购使Noramco能够为我们的客户提供超越API的更多采购选项。凭借这些额外功能，Noramco/Purisys客户可以为临床和商业目的开发用于API的药品配方。“之前经营过Halo制药业务，我直接了解这两个网站的功能，期待与现有和未来客户合作，同时欢迎近400名新员工加入Noramco公司集团。”。

About Noramco

关于Noramco

Headquartered in Wilmington Delaware, Noramco is a global supplier of active ingredients (APIs) including controlled substances to the pharmaceutical industry. Noramco’s APIs are used by many of the leading brand and generic pharma companies as well as small to mid- scale pharma companies. Noramco’s APIs are used in over 350 products and sold in over 30 counties.

Noramco总部设在特拉华州威尔明顿，是一家全球有效成分（API）供应商，包括制药行业的受控物质。Noramco的API被许多领先的品牌和通用制药公司以及中小型制药公司所使用。Noramco的API用于350多种产品，并在30多个县销售。

Noramco manufactures APIs that are used across a broad set of indications such as ADHD, pain management and abuse treatment and prevention..

Noramco生产的API用于广泛的适应症，如ADHD，疼痛管理和滥用治疗和预防。。

About Purisys

关于Purisys

Headquartered in Athens Georgia, Purisys is a leading supplier of API CDMO services and pharmaceutical reference standards. Its 17,000-square-foot manufacturing facility and innovation center is staffed by scientists, engineers, and other professionals who have decades of experience in complex high-barrier custom synthetic chemistry.

Purisys总部设在乔治亚州雅典，是API CDMO服务和药物参考标准的领先供应商。其17000平方英尺的制造设施和创新中心由科学家，工程师和其他专业人员组成，他们在复杂的高屏障定制合成化学方面拥有数十年的经验。

Purisys’ CDMO services are designed to support the development of custom APIs for a wide range of clinical and niche commercial applications. Purisys has specialized capabilities in controlled substance APIs, possessing 6 DEA registrations encompassing 48 drug codes. Purisys stocks a catalog of more than 250 commercial reference standards that support pharmaceutical drug product development and manufacturing..

Purisys的CDMO服务旨在支持为广泛的临床和利基商业应用开发定制API。Purisys拥有受控物质API的专业能力，拥有6个DEA注册，涵盖48个药品代码。Purisys拥有超过250种商业参考标准的目录，支持药品开发和制造。。

View source version on businesswire.com: https://www.businesswire.com/news/home/20231102572124/en/

在businesswire.com上查看源版本：https://www.businesswire.com/news/home/20231102572124/en/

Contacts

联络

Jeremy Milner

Jeremy Milner

BackBay Communications

后退通信

jeremy.milner@backbaycommunications.com

jeremy.milner@backbaycommunications.com

(401) 862-9422

(401) 862-9422

Source: Noramco

来源：Noramco

View this news release online at:

在线查看此新闻稿：

http://www.businesswire.com/news/home/20231102572124/en

http://www.businesswire.com/news/home/20231102572124/en